Pfizer Inc.,   USA

Tablets, film-coated 250 mg + 125 mg, 500 mg + 125 mg, 875 mg + 125 mg.

Tablets, film-coated, 5 mg and 10 mg.

Film-coated tablets, 25 mg, 50 mg or 100 mg.

Capsules 20 mg.

Powder for suspension for oral administration, 40 mg / ml.

Capsules, 150 mg and 300 mg.

Lyophilizate for the preparation of a solution for intramuscular injection of 30 mg.

Capsules 75 mg, 100 mg and 125 mg.

Tablets coated with a film coat of 1 mg and 5 mg.

Tablets coated with a film coating, 25 mg or 50 mg.

Tablets of prolonged action, covered with a film coat of 4 mg, 8 mg.

Tablets 5 mg, 10 mg, 20 mg.

Capsules 200 mg and 250 mg

For 10 capsules in a PVC / aluminum blister.

For 1 or 6 blisters together with instructions for use in a cardboard bundle.

Capsules, 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg or 300 mg.

Suspension for intramuscular injection 0.5 ml / dose.

Tablets, film-coated, 20 mg.

For 0.6 ml of the drug in bottles of colorless optical glass type I (Hebrew F.), hermetically sealed with butyl rubber stoppers and rolled up with aluminum caps equipped with detachable plastic disks of the type "flip-off".

1 bottle along with the instruction for use is placed in a cardboard box or 1 bottle complete with 1 disposable syringe with a capacity of 1 ml with a built-in injection needle in a contour pack (blister) and 2 individually packed alcoholic napkins placed in plastic packaging and sealed with laminated paper.

For 2 or 7 plastic packages, together with the instructions for use are placed in a cardboard box.

Tablets, film-coated 20 mg or 40 mg.

Lyophilizate for solution for intravenous administration, 250 ME, 500 ME, 1000 ME and 2000 ME.

lyophilizate for solution for injection

Tablets 125 mg, 250 mg.

7 tablets in a blister of PVC / PVDC / film and aluminum foil.

2 blisters together with instructions for use in a cardboard bundle.

Lyophilizate for solution preparation for infusions of 50 mg.

50 mg of tigecycline per vial of colorless glass (type I) with a capacity of 5 ml, Corked with a rubber stopper and rolled up with an aluminum cap with a plastic cap like "flip-off". 10 vials with instructions for application in a cardboard box.

Tablets of prolonged action, 4 mg and 8 mg.

Concentrate for the preparation of a solution for infusions of 30 mg.

For 30 mg / 1.2 ml in bottles of transparent glass with a nominal capacity of 4 ml, sealed with a rubber butyl rubber stopper coated with fluoropolymer and rolled aluminum cap, equipped plastic detachable cap.

For 1.8 ml of solvent in bottles of transparent glass with a nominal capacity of 3 ml,ukuporennyh Butyl rubber stopper with a fluoropolymer coating and rolled aluminum cap, equipped plastic detachable cap.

For 1 vial of concentrate with a solvent (1 bottle), together with instructions for use in a cardboard pack.

Suspension for intramuscular injection, 0.5 ml / dose.

Lyophilizate for solution for injection, 100 mg, 500 mg, 1000 mg.

Tablets, film-coated, 0.5 mg or 1 mg.

Liofilizate for the preparation of concentrate for the preparation of a solution for infusion 200 units.

Solution for subcutaneous administration, 50 mg / ml.

Lyophilizate for the preparation of a solution for subcutaneous administration, 25 mg.